Cite
HARVARD Citation
Santagostino, E. et al. (2021). Safety and efficacy of BAY 94–9027, an extended‐half‐life factor VIII, during minor surgical procedures in patients with severe haemophilia A. Haemophilia. 27 (4), pp. e559-e562. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Santagostino, E. et al. (2021). Safety and efficacy of BAY 94–9027, an extended‐half‐life factor VIII, during minor surgical procedures in patients with severe haemophilia A. Haemophilia. 27 (4), pp. e559-e562. [Online].